[HTML][HTML] Probing the acceptor active site organization of the human recombinant β1, 4-galactosyltransferase 7 and design of xyloside-based inhibitors
M Saliba, N Ramalanjaona, S Gulberti… - Journal of Biological …, 2015 - ASBMB
Among glycosaminoglycan (GAG) biosynthetic enzymes, the human β1, 4-
galactosyltransferase 7 (hβ4GalT7) is characterized by its unique capacity to take over …
galactosyltransferase 7 (hβ4GalT7) is characterized by its unique capacity to take over …
Probing the Acceptor Active Site Organization of the Human Recombinant beta 1, 4-Galactosyltransferase 7 and Design of Xyloside-based Inhibitors
M Saliba, N Ramalanjaona, S Gulberti… - Journal of Biological …, 2015 - hero.epa.gov
Background: Glycosyltransferase inhibitors have important applications in therapeutics and
as chemical biology tools. Results: The human 1, 4-galactosyltransferase 7 enzyme active …
as chemical biology tools. Results: The human 1, 4-galactosyltransferase 7 enzyme active …
Probing the Acceptor Active Site Organization of the Human Recombinant beta 1, 4-Galactosyltransferase 7 and Design of Xyloside-based Inhibitors
M Saliba, N Ramalanjaona, S Gulberti… - Journal of Biological …, 2015 - hal.univ-lorraine.fr
Background: Glycosyltransferase inhibitors have important applications in therapeutics and
as chemical biology tools. Results: The human 1, 4-galactosyltransferase 7 enzyme active …
as chemical biology tools. Results: The human 1, 4-galactosyltransferase 7 enzyme active …
Probing the acceptor active site organization of the human recombinant β1, 4-galactosyltransferase 7 and design of xyloside-based inhibitors.
M Saliba, N Ramalanjaona, S Gulberti… - The Journal of …, 2015 - europepmc.org
Among glycosaminoglycan (GAG) biosynthetic enzymes, the human β1, 4-
galactosyltransferase 7 (hβ4GalT7) is characterized by its unique capacity to take over …
galactosyltransferase 7 (hβ4GalT7) is characterized by its unique capacity to take over …
[HTML][HTML] Probing the Acceptor Active Site Organization of the Human Recombinant β1, 4-Galactosyltransferase 7 and Design of Xyloside-based Inhibitors
M Saliba, N Ramalanjaona, S Gulberti… - Journal of Biological …, 2015 - Elsevier
Among glycosaminoglycan (GAG) biosynthetic enzymes, the human β1, 4-
galactosyltransferase 7 (hβ4GalT7) is characterized by its unique capacity to take over …
galactosyltransferase 7 (hβ4GalT7) is characterized by its unique capacity to take over …
[PDF][PDF] Probing the acceptor active site organization of the human recombinant β1, 4-galactosyltransferase 7 and design of xyloside-based inhibitors
M Saliba, N Ramalanjaona, S Gulberti, I Bertin-Jung… - 2015 - unsed.org
Background: Glycosyltransferase inhibitors have important applications in therapeutics and
as chemical biology tools. Results: The human β1, 4-galactosyltransferase 7 enzyme active …
as chemical biology tools. Results: The human β1, 4-galactosyltransferase 7 enzyme active …
Probing the acceptor active site organization of the human recombinant β1, 4-galactosyltransferase 7 and design of xyloside-based inhibitors
M Saliba, N Ramalanjaona… - The Journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
Among glycosaminoglycan (GAG) biosynthetic enzymes, the human β1, 4-
galactosyltransferase 7 (hβ4GalT7) is characterized by its unique capacity to take over …
galactosyltransferase 7 (hβ4GalT7) is characterized by its unique capacity to take over …
[PDF][PDF] Probing the Acceptor Active Site Organization of the Human Recombinant ß1, 4-Galactosyltransferase 7 and Design of Xyloside-based Inhibitors
M Saliba, N Ramalanjaona, S Gulberti… - THE JOURNAL OF …, 2015 - academia.edu
Background: Glycosyltransferase inhibitors have important applications in therapeutics and
as chemical biology tools. Results: The human ß1, 4-galactosyltransferase 7 enzyme active …
as chemical biology tools. Results: The human ß1, 4-galactosyltransferase 7 enzyme active …
[HTML][HTML] Probing the Acceptor Active Site Organization of the Human Recombinant β1, 4-Galactosyltransferase 7 and Design of Xyloside-based Inhibitors
M Saliba, N Ramalanjaona, S Gulberti… - The Journal of …, 2015 - ncbi.nlm.nih.gov
Results: The human β1, 4-galactosyltransferase 7 enzyme active site was mapped by
modeling, mutagenesis, and in vitro/in cellulo assays, and novel inhibitors were synthesized …
modeling, mutagenesis, and in vitro/in cellulo assays, and novel inhibitors were synthesized …
[引用][C] Probing the Acceptor Active Site Organization of the Human Recombinant β1, 4-Galactosyltransferase 7 and Design of Xyloside-based Inhibitors
M Saliba, N Ramalanjaona, S Gulberti… - Journal of Biological …, 2015 - cir.nii.ac.jp
Probing the Acceptor Active Site Organization of the Human Recombinant β1,4-Galactosyltransferase
7 and Design of Xyloside-based Inhibitors | CiNii Research CiNii 国立情報学研究所 学術情報 …
7 and Design of Xyloside-based Inhibitors | CiNii Research CiNii 国立情報学研究所 学術情報 …